All terms in GO
| Label | Id | Description |
|---|---|---|
| response to olanzapine | GO_0097333 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.] |
| response to perphenazine | GO_0097334 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.] |
| response to quetiapine | GO_0097335 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.] |
| response to risperidone | GO_0097336 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.] |
| response to ziprasidone | GO_0097337 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.] |
| response to clozapine | GO_0097338 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.] |
| glycolate transmembrane transport | GO_0097339 | [The process in which glycolate is transported across a membrane. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).] |
| glycolate transport | GO_1900866 | [The directed movement of a glycolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| positive regulation of cell-cell adhesion mediated by cadherin | GO_2000049 | [Any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.] |
| negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | GO_2000054 | [Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.] |
| regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | GO_2000053 | [Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.] |
| positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | GO_2000055 | [Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.] |
| non-canonical Wnt signaling pathway | GO_0035567 | [The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via effectors other than beta-catenin.] |
| regulation of proteolysis involved in cellular protein catabolic process | GO_1903050 | [Any process that modulates the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.] |
| negative regulation of ubiquitin-dependent protein catabolic process | GO_2000059 | [Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process] |
| negative regulation of proteolysis involved in cellular protein catabolic process | GO_1903051 | [Any process that stops, prevents or reduces the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.] |
| regulation of Wnt signaling pathway involved in digestive tract morphogenesis | GO_2000056 | [Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.] |
| negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis | GO_2000057 | [Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.] |
| negative regulation of cysteine-type endopeptidase activity | GO_2000117 | [Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.] |
| zymogen inhibition | GO_0097341 | [Any process that prevents the proteolytic processing of an inactive enzyme to an active form.] |